Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study.

Saved in:
Bibliographic Details
Title: Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study.
Authors: Tseng KY; Division of Medical Oncology, Department of Oncology, Taichung Veterans General Hospital, Taichung, Taiwan., Hsu CY; Biostatistics Task Force, Taichung Veterans General Hospital, Taichung, Taiwan., Wu CH; Division of Medical Oncology, Department of Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan., Shih YH; Division of Medical Oncology, Department of Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan., Lin HC; Division of Medical Oncology, Department of Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Feb 21; Vol. 18, pp. 17588359261420081. Date of Electronic Publication: 2026 Feb 21 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1758-8340
DOI:10.1177/17588359261420081